Strong opioids for noncancer pain due to musculoskeletal diseases: Not more effective than acetaminophen or NSAIDs.

[1]  S. Brynelson Pharmacological Interventions for Prevention or Treatment of Postoperative Pain in People Undergoing Laparoscopic Cholecystectomy. , 2016, Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses.

[2]  P. Wiffen,et al.  Oral morphine for cancer pain. , 2016, The Cochrane database of systematic reviews.

[3]  R. Day,et al.  Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial , 2014, BDJ.

[4]  B. Kuehn,et al.  Driven by prescription drug abuse, heroin use increases among suburban and rural whites. , 2014, JAMA.

[5]  P. Romundstad,et al.  Chronic pain and use of opioids: A population-based pharmacoepidemiological study from the Norwegian Prescription Database and the Nord-Trøndelag Health Study , 2014, PAIN®.

[6]  R. Kream,et al.  Epigenetic modification of DRG neuronal gene expression subsequent to nerve injury: Etiological contribution to complex regional pain syndromes (Part I) , 2014, Medical science monitor : international medical journal of experimental and clinical research.

[7]  R. Moore,et al.  Oxycodone for neuropathic pain and fibromyalgia in adults. , 2014, The Cochrane database of systematic reviews.

[8]  V. Martinez,et al.  Opioid-induced hyperalgesia in patients after surgery: a systematic review and a meta-analysis. , 2014, British journal of anaesthesia.

[9]  R. Urman,et al.  The role of analgesics in cancer propagation. , 2014, Best practice & research. Clinical anaesthesiology.

[10]  C. Kien,et al.  Extended‐release opioids in the management of cancer pain: A systematic review of efficacy and safety , 2014, European journal of pain.

[11]  A. Saraux,et al.  High pain catastrophizing scores in one-fourth of patients on biotherapy for spondylarthritis or rheumatoid arthritis. , 2014, Joint, bone, spine : revue du rhumatisme.

[12]  I. Riphagen,et al.  Long‐ or short‐acting opioids for chronic non‐malignant pain? A qualitative systematic review , 2014, Acta anaesthesiologica Scandinavica.

[13]  Karen L. Price,et al.  The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis , 2014, BMC Musculoskeletal Disorders.

[14]  A. Barikani,et al.  The Postoperative Analgesic Effect of Morphine and Paracetamol in the Patients Undergoing Laparotomy, Using PCA Method , 2013, Global journal of health science.

[15]  B. Sites,et al.  Pain policy and abuse of prescription opioids in the USA: a cautionary tale for Europe , 2013, Anaesthesia.

[16]  A. Dennis The bench is the bedside – the role of transthoracic echocardiography in translating pregnancy research into clinical practice , 2013, Anaesthesia.

[17]  Joanne W. Y. Chung,et al.  Drug therapy for the treatment of chronic nonspecific low back pain: systematic review and meta-analysis. , 2013, Pain physician.

[18]  R. Dworkin,et al.  Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations , 2013, PAIN®.

[19]  Howard S. Smith,et al.  Chronic pain treatment with opioid analgesics: benefits versus harms of long-term therapy , 2013, Expert review of neurotherapeutics.

[20]  P. Wiffen,et al.  Transdermal fentanyl for cancer pain. , 2013, The Cochrane database of systematic reviews.

[21]  P. Ryan,et al.  Comparison of the risks of opioid abuse or dependence between tapentadol and oxycodone: results from a cohort study. , 2013, The journal of pain : official journal of the American Pain Society.

[22]  S. Atlas,et al.  Opioids compared to placebo or other treatments for chronic low-back pain. , 2013, The Cochrane database of systematic reviews.

[23]  I. Sutton,et al.  Controlled-release oxycodone and naloxone in the treatment of chronic low back pain: a placebo-controlled, randomized study. , 2013, Pain research & management.

[24]  M. Serinken,et al.  Intravenous paracetamol versus dexketoprofen versus morphine in acute mechanical low back pain in the emergency department: a randomised double-blind controlled trial , 2013, Emergency Medicine Journal.

[25]  D. Webster,et al.  Rethinking opioid prescribing to protect patient safety and public health. , 2012, JAMA.

[26]  B. Kuehn Petition targets painkiller marketing in effort to curb overdose deaths. , 2012, JAMA.

[27]  M. Angst,et al.  Analgesic tolerance without demonstrable opioid-induced hyperalgesia: A double-blinded, randomized, placebo-controlled trial of sustained-release morphine for treatment of chronic nonradicular low-back pain , 2012, PAIN®.

[28]  E. Bruera,et al.  A systematic review of randomized trials on the effectiveness of opioids for cancer pain. , 2012, Pain physician.

[29]  C. Clarke,et al.  Opioid-induced hyperalgesia: a review of epidemiology, mechanisms and management. , 2012, Singapore medical journal.

[30]  B. Bannwarth,et al.  Nonspecific low back pain: assessment of available medications. , 2012, Joint, bone, spine : revue du rhumatisme.

[31]  H. Vo,et al.  Long-acting morphine following hip or knee replacement: a randomized, double-blind, placebo-controlled trial. , 2012, Pain research & management.

[32]  C. Schultz,et al.  Intravenous paracetamol versus morphine for renal colic in the emergency department: a randomised double-blind controlled trial , 2011, Emergency Medicine Journal.

[33]  W. Stewart,et al.  Prevalence of Prescription Opioid-Use Disorder Among Chronic Pain Patients: Comparison of the DSM-5 vs. DSM-4 Diagnostic Criteria , 2011, Journal of addictive diseases.

[34]  A. Caraceni,et al.  Is oral morphine still the first choice opioid for moderate to severe cancer pain? A systematic review within the European Palliative Care Research Collaborative guidelines project , 2011, Palliative medicine.

[35]  J. Benger,et al.  Randomised comparison of intravenous paracetamol and intravenous morphine for acute traumatic limb pain in the emergency department , 2011, Emergency Medicine Journal.

[36]  H. Sorgatz,et al.  Opioid use in chronic noncancer pain: guidelines revisited , 2010, Current opinion in anaesthesiology.

[37]  M. Hale,et al.  Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain , 2010, Current medical research and opinion.

[38]  J. L. R. Martin,et al.  Systematic review and meta-analysis of cannabis treatment for chronic pain. , 2009, Pain medicine.

[39]  C. Eken,et al.  Intravenous paracetamol or morphine for the treatment of renal colic: a randomized, placebo-controlled trial. , 2009, Annals of emergency medicine.

[40]  R. Chou,et al.  Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. , 2009, The journal of pain : official journal of the American Pain Society.

[41]  A. Zee The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy , 2009 .

[42]  J. Ballantyne,et al.  Efficacy of Opioids for Chronic Pain: A Review of the Evidence , 2008, The Clinical journal of pain.

[43]  M. Max,et al.  Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain , 2007, PAIN.

[44]  Ackerman We rd Paroxysmal opioid-induced pain and hyperalgesia. , 2006 .

[45]  E. Kalso,et al.  Controlled clinical trials in cancer pain. How controlled should they be? A qualitative systematic review , 2006, British Journal of Cancer.

[46]  P. Hoskin,et al.  Controlled‐release morphine in cancer pain , 1989, Anaesthesia.

[47]  P. Richette How safe is acetaminophen in rheumatology? , 2014, Joint, bone, spine : revue du rhumatisme.

[48]  H. Flor,et al.  Evidence of specific cognitive deficits in patients with chronic low back pain under long-term substitution treatment of opioids. , 2014, Pain physician.

[49]  S. Perrot,et al.  Relieving pain in rheumatology patients: repetitive transcranial magnetic stimulation (rTMS), a developing approach. , 2014, Joint, bone, spine : revue du rhumatisme.

[50]  A. Davies,et al.  Opioids for the management of breakthrough pain in cancer patients. , 2013, The Cochrane database of systematic reviews.

[51]  P. Wiffen,et al.  Transdermal fentanyl for cancer pain (Review) , 2013 .

[52]  P. Wiffen,et al.  Oral morphine for cancer pain. , 2013, The Cochrane database of systematic reviews.

[53]  Hans Hansen,et al.  American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance. , 2012, Pain physician.

[54]  L. Delaunay,et al.  Anaesthesia by non-anaesthesiologists: the Pandora Box is open! , 2012, European journal of anaesthesiology.

[55]  B. Bannwarth Irrelevance of the WHO analgesic ladder for managing rheumatic pain. , 2010, Joint, bone, spine : revue du rhumatisme.

[56]  O. Vidal,et al.  Tramadol in the Treatment of Neuropathic Cancer Pain , 2007, Clinical drug investigation.

[57]  W. Ackerman Paroxysmal opioid-induced pain and hyperalgesia. , 2006, The Journal of the Kentucky Medical Association.

[58]  J. Nizard,et al.  Do we use morphine often enough? An opinion survey in 100 rheumatology department patients. , 2000, Joint, bone, spine : revue du rhumatisme.

[59]  E. Eisenberg,et al.  Opioids for neuropathic pain ( Review ) Eisenberg , 2022 .